Depression and Diabetes Treatment Nonadherence: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Depression is common in patients with diabetes and is associated with worse treatment outcomes. Its relationship to treatment adherence, however, has not been systematically reviewed. We used meta-analysis to examine the relationship between depression and treatment nonadherence in patients with type 1 and type 2 diabetes. RESEARCH DESIGN AND METHODS—We searched MEDLINE and PsycINFO databases for all studies published by June 2007 and reviewed references of published articles. Meta-analytic procedures were used to estimate the effect size r in a random effects model. Significance values, weighted effect sizes, 95% CIs, and tests of homogeneity of variance were calculated. RESULTS—Results from 47 independent samples showed that depression was significantly associated with nonadherence to the diabetes treatment regimen (z = 9.97, P < 0.0001). The weighted effect size was near the medium range (r = 0.21, 95% CI 0.17–0.25). Moderator analyses showed that the effect was significantly larger in studies that measured self-care as a continuous versus categorical variable (P = 0.001). Effect sizes were largest for missed medical appointments and composite measures of self-care (r values = 0.31, 0.29). Moderation analyses suggest that effects for most other types of self-care are also near the medium range, especially in studies with stronger methodologies. CONCLUSIONS—These findings demonstrate a significant association between depression and treatment nonadherence in patients with diabetes. Studies that used stronger methodologies had larger effects. Treatment nonadherence may represent an important pathway between depression and worse diabetes clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Suboptimal self-management may be due to functional limitations (e.g., blindness, problems with dexterity, low health literacy and numeracy), lack of appropriate diabetes education, forgetting and disruption in routines,”
From Psychosocial care for people with diabetes: a position statement of the American Diabetes Association (2016) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The adverse effect of psychological stress on health behaviours such as food choice, physical activity and adherence to medication also contributes to T2DM risk”
From Type 2 diabetes mellitus and psychological stress — a modifiable risk factor (2017) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In people with existing diabetes mellitus, evidence from a meta-analysis indicates that comorbid depression increases non-adherence to a range of behaviours including diet, medication usage and exercise 62 .”
From Type 2 diabetes mellitus and psychological stress — a modifiable risk factor (2017) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Comorbid MDD in people with type 2 diabetes is associated with poorer adherence to diabetes treatment52 and self-care activities (e.g., exercise, healthy eating)53,54, increased health care costs22,54, reduced glycemic control55,56, and increased hospital admissions and complications57-60.”
From Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management (2023) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“We evaluated the significance of variability among effect sizes by calculating the Q statistic and quantified the degree of dispersion of effect sizes with an Isquared index, which serves as a ratio of the variance between studies to total variance (21).”
MethodStatistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
(2000) · Cited by 9,198
Meta-Analytic Procedures for Social Research.
Metcalfe, A., & Rosenthal, R. (1994) · The Statistician · doi:10.2307/2348600 · Cited by 4,249
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177 · cited 3×
“(7) based on a meta-analysis of 12 studies of patients adhering to treatment regimens of other chronic illnesses.”
BackgroundInfluentialA Fail-Safe N for Effect Size in Meta-Analysis
Orwin, R. G. (1983) · Journal of Educational Statistics · doi:10.2307/1164923 · Cited by 2,064 · cited 1×
“05 level, chosen as an effect size that would be trivial (23).”
BackgroundDepression and poor glycemic control: a meta-analytic review of the literature.
Lustman, P. J., Anderson, R. J., Freedland, K. E., de Groot, M., Carney, R. M., & Clouse, R. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.934 · Cited by 1,854
Association of depression and diabetes complications: a meta-analysis
de Groot, M., Anderson, R., Freedland, K. E., Clouse, R. E., & Lustman, P. J. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00015 · Cited by 1,799 · cited 2×
“P atients with diabetes are more likely to experience depression than the general population, and the presence of depression is associated with poorer quality of life (1), increases in hyperglycemia (2), health care utilization (3), risk of complications (4,5), functional impairment (6), and risk of mortality (5).”
BackgroundMethodOn the Use of Beta Coefficients in Meta-Analysis.
Peterson, R. A., & Brown, S. P. (2005) · Journal of Applied Psychology · doi:10.1037/0021-9010.90.1.175 · Cited by 1,643 · cited 1×
“05 , where is an indicator variable that equals 1 when is nonnegative and 0 when is negative (20).”
Background
Cited by
Items 101–200 of 1,000
Validity of Medication Adherence Self-Reports in Adults With Type 2 Diabetes
Gonzalez, J. S., Schneider, H. E., Wexler, D. J., Psaros, C., Delahanty, L. M., Cagliero, E., & Safren, S. A. (2013) · Diabetes Care · doi:10.2337/dc12-0410 · Cited by 104
“Because depression has been consistently associated with treatment nonadherence in diabetes, including self-reported and objectively monitored adherence (14), and in light of the literature linking mood and biases in memory and recall (15–17), we also used a detailed assessment of depression to evaluate whether depres…”
BackgroundMethodSelf-citationMarinho, F. D. S., Moram, C. B. D. M., Rodrigues, P. C., Leite, N. C., Salles, G. F., & Cardoso, C. R. L. (2018) · Journal of Diabetes Research · doi:10.1155/2018/8970196 · Cited by 117
“Depression has been frequently associated with selfreported worse treatment adherence in patients with diabetes [4, 30].”
BackgroundNovak, M., Mucsi, I., Rhee, C. M., Streja, E., Lu, J. L., Kalantar-Zadeh, K., Molnar, M. Z., & Kovesdy, C. P. (2016) · Diabetes Care · doi:10.2337/dc16-0048 · Cited by 104
“CVD 167,682 (18) 69,261 (20) 98,421 (17)”
BackgroundKongkaew, C., Jampachaisri, K., Chaturongkul, C. A., & Scholfield, C. N. (2013) · European Journal of Pediatrics · doi:10.1007/s00431-013-2128-y · Cited by 108
“29 [15] compared to the effect size of 0.”
BackgroundMethodInfluentialBeverly, E. A., Ganda, O. P., Ritholz, M. D., Lee, Y., Brooks, K. M., Lewis-Schroeder, N. F., Hirose, M., & Weinger, K. (2012) · Diabetes Care · doi:10.2337/dc11-2422 · Cited by 97
“Diabetic patients experience disproportionately high rates of social and emotional difficulties compared with the general population (16,20,21).”
BackgroundEbert, D. D., Nobis, S., Lehr, D., Baumeister, H., Riper, H., Auerbach, R. P., Snoek, F., Cuijpers, P., & Berking, M. (2017) · Diabetic Medicine · doi:10.1111/dme.13173 · Cited by 101
Mendes, R., Martins, S. P. V., & Fernandes, L. P. N. S. (2019) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3894 · Cited by 117
“Besides, poor metabolic control may lead to complications, which may be associated with worsening depression [30, 33, 85].”
BackgroundEcheverry, D., Duran, P., Bonds, C., Lee, M., & Davidson, M. B. (2009) · Diabetes Care · doi:10.2337/dc09-0785 · Cited by 99
Epidemiology of depression in diabetes: International and cross-cultural issues
Lloyd, C. E., Roy, T., Nouwen, A., & Chauhan, A. M. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70005-8 · Cited by 111
Zhang, Y., Ting, R. Z., Yang, W., Jia, W., Li, W., Ji, L., Guo, X., Kong, A. P., Wing, Y., Luk, A. O., et al. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12238 · Cited by 96
“In a meta-analysis of 47 cohort studies, depression was associated with poor self-care, medication non-adherence and frequent defaults.(29) Congruent to these observations, we also found that the group with probable depression were less likely to adhere to general diet and physical exercise, and had higher rates of me…”
MethodDepressive Symptoms, Low Adherence, and Poor Asthma Outcomes in the Elderly
Krauskopf, K., Sofianou, A., Goel, M. S., Wolf, M. S., Wilson, E. A. H., Martynenko, M., Halm, E. A., Leventhal, H., Feldman, J. M., Federman, A. D., et al. (2013) · Journal of Asthma · doi:10.3109/02770903.2012.757779 · Cited by 106
Carper, M. M., Traeger, L., Gonzalez, J. S., Wexler, D. J., Psaros, C., & Safren, S. A. (2014) · Journal of Behavioral Medicine · doi:10.1007/s10865-013-9505-x · Cited by 88
“However, another study showed that the number of depressive symptoms was more closely related with T2DM self-management than diabetes distress, even when those who were likely to meet criteria for major depressive disorder were excluded (Gonzalez et al., 2008).”
BackgroundResultSelf-citationDepression predicts first but not recurrent diabetic foot ulcers
Gonzalez, J. S., Vileikyte, L., Ulbrecht, J. S., Rubin, R. R., Garrow, A. P., Delgado, C., Cavanagh, P. R., Boulton, A. J. M., & Peyrot, M. (2010) · Diabetologia · doi:10.1007/s00125-010-1821-x · Cited by 96
“Although there is a strong evidence base to suggest that depression is associated with poorer self-care and non-adherence to diabetes treatment [14], depression is also associated with alterations in immune system responses to infection and injury [33], and neuroendocrine changes—specifically activation of the hypotha…”
BackgroundResultSelf-citationBasiri, R., Seidu, B., & Rudich, M. (2023) · Nutrients · doi:10.3390/nu15194226 · Cited by 114
“This raises the possibility that there may be a mutually reinforcing phenomenon in which reduced self-care compliance increases blood glucose levels, which may contribute to depressive symptoms [35,36].”
BackgroundBeverly, E. A., Ritholz, M. D., Brooks, K. M., Hultgren, B. A., Lee, Y., Abrahamson, M. J., & Weinger, K. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2070-0 · Cited by 109
Depression in type 2 diabetes mellitus—A brief review
Siddiqui, S. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.06.010 · Cited by 104
Metabolic and Inflammatory Links to Depression in Youth With Diabetes
Hood, K. K., Lawrence, J. M., Anderson, A., Bell, R., Dabelea, D., Daniels, S., Rodriguez, B., Dolan, L. M., & for the SEARCH for Diabetes in Youth Study Group (2012) · Diabetes Care · doi:10.2337/dc11-2329 · Cited by 92
“Depression is linked to poorer diabetes management and control in both children and adults (2,3).”
BackgroundRegional Brain Gray Matter Changes in Patients with Type 2 Diabetes Mellitus
Roy, B., Ehlert, L., MULLUR, R. S., Freeby, M., Woo, M. A., Kumar, R., & CHOI, S. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-67022-5 · Cited by 98
Browne, J. L., Nefs, G., Pouwer, F., & Speight, J. (2015) · Diabetic Medicine · doi:10.1111/dme.12566 · Cited by 89
Type 1 Diabetes in Children and Adolescents
Wherrett, D. K., Ho, J., Huot, C., Legault, L., Nakhla, M. M., & Rosolowsky, E. T. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.036 · Cited by 120
Fletcher-Brown, J., Turnbull, S., Viglia, G., Chen, T., & Pereira, V. (2021) · International Journal of Research in Marketing · doi:10.1016/j.ijresmar.2020.06.002 · Cited by 86
Cascini, S., Agabiti, N., Davoli, M., Uccioli, L., Meloni, M., Giurato, L., Marino, C., & Bargagli, A. M. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001355 · Cited by 101
Safren, S. A., O'Cleirigh, C., Andersen, L. S., Magidson, J. F., Lee, J. S., Bainter, S. A., Musinguzi, N., Simoni, J., Kagee, A., & Joska, J. A. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25823 · Cited by 82
“Given the prevalence of depression and its association with poor adherence, not only in HIV [3] but across medical conditions [6], it is important to treat depression in HIV for quality of life improvements and HIV control [7].”
BackgroundSelf-citationPetrak, F., Herpertz, S., Albus, C., Hermanns, N., Hiemke, C., Hiller, W., Kronfeld, K., Kruse, J., Kulzer, B., Ruckes, C., et al. (2015) · Diabetes Care · doi:10.2337/dc14-1599 · Cited by 82
A review of the mental health issues of diabetes conference
Ducat, L., Rubenstein, A., Philipson, L. H., & Anderson, B. J. (2015) · Diabetes Care · doi:10.2337/dc14-1383 · Cited by 87
Hudson, J. L., Bundy, C., Coventry, P. A., & Dickens, C. M. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.02.004 · Cited by 98
“ac systematic reviewwithmeta-analysis (n=47) showed important relationships between increased depressive symptoms and lower diabetes self-care adherence across a range of diabetes self-care outcome measures [9].”
BackgroundBarriers and solutions to diabetes management: an Indian perspective
Wangnoo, S., Maji, D., Das, A., Rao, P., Moses, A., Sethi, B., Unnikrishnan, A., Kalra, S., Balaji, V, Bantwal, G., et al. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.113749 · Cited by 66
Schmitz, N., Gariépy, G., Smith, K. J., Clyde, M., Malla, A., Boyer, R., Strychar, I., Lesage, A., & Wang, J. (2014) · Diabetes Care · doi:10.2337/dc13-1832 · Cited by 80
“We considered six categories for depression status (1): no/minimal depression, participants with PHQ-9 scores of 4 or less at all four assessments (2); one subthreshold episode, participants with PHQ-9 scores between 5 and 14 at one assessment and lower scores at the other assessments (3); two subthreshold episodes, p…”
BackgroundMethodPsychological distress, self-efficacy and glycemic control in type 2 diabetes
Indelicato, L., Dauriz, M., Santi, L., Bonora, F., Negri, C., Cacciatori, V., Targher, G., Trento, M., & Bonora, E. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.01.006 · Cited by 95
“Additionally, while depression is associated with poorer adherence to therapeutic regimens [9], higher occurrence of medical complications [10] and higher hospitalization rates [11], currently there is a paucity of information about the correlates and consequences of anxiety symptoms on T2D clinical outcomes.”
BackgroundBeran, M., Muzambi, R., Geraets, A., Albertorio‐Diaz, J. R., Adriaanse, M. C., Iversen, M. M., Kokoszka, A., Nefs, G., Nouwen, A., Pouwer, F., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14671 · Cited by 82
Silva, N., Atlantis, E. E., & Ismail, K. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0245-8 · Cited by 89
Gonzalez, J. S., Kane, N. S., Binko, D. H., Shapira, A., & Hoogendoorn, C. J. (2016) · Diabetes Care · doi:10.2337/dc16-1657 · Cited by 80
Self-citationJones, A., Vallis, M., & Pouwer, F. (2015) · Diabetic Medicine · doi:10.1111/dme.12620 · Cited by 79
Applebaum, A. J., Lichtenthal, W. G., Pessin, H. A., Radomski, J. N., Simay Gökbayrak, N., Katz, A. M., Rosenfeld, B., & Breitbart, W. (2012) · Psycho-Oncology · doi:10.1002/pon.2013 · Cited by 75
Psychosoziales und Diabetes (Teil 1)
Kulzer, B., Albus, C., Herpertz, S., Kruse, J., Lange, K., Lederbogen, F., & Petrak, F. (2013) · Diabetologie und Stoffwechsel · doi:10.1055/s-0033-1335785 · Cited by 98
Ehrmann, D., Kulzer, B., Haak, T., & Hermanns, N. (2015) · Diabetic Medicine · doi:10.1111/dme.12861 · Cited by 83
Kidia, K., Machando, D., Bere, T., Macpherson, K., Nyamayaro, P., Potter, L., Makadzange, T., Munjoma, R., Marufu, M., Araya, R., et al. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12502 · Cited by 67
“CMDs, especially depression, are often comorbid with other chronic illnesses, such as diabetes [3], epilepsy [4], cardiovascular disease [5], and HIV/ AIDS [6-8].”
BackgroundSelf-citationSCHMITT, A. J., Reimer, A., Hermanns, N., Kulzer, B., Ehrmann, D., Krichbaum, M., Huber, J., & Haak, T. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.12.015 · Cited by 81
Bakhach, M., Reid, M. W., Pyatak, E. A., Berget, C., Cain, C., Thomas, J. “., Klingensmith, G. J., & Raymond, J. K. (2019) · The Diabetes Educator · doi:10.1177/0145721719858080 · Cited by 73
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Cummings, D. M., Kirian, K., Howard, G., Howard, V., Yuan, Y., Muntner, P., Kissela, B., Redmond, N., Judd, S. E., & Safford, M. M. (2016) · Diabetes Care · doi:10.2337/dc15-1174 · Cited by 73
“We (11) and others (3,4) have shown that”
BackgroundPrevalence of depression in type 2 diabetes patients in German primary care practices
Jacob, L., & Kostev, K. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.12.013 · Cited by 75
“More recently, anothermeta-analysis indicated a significant link between treatment non-adherence in diabetes and depression (Gonzalez et al., 2008), underlining the tenuous link between the mental disorder and treatments regulating glycaemia, at least in cases of type 2 diabetes (Zhang et al.,…”
BackgroundSobolewska-Nowak, J., Wachowska, K., Nowak, A., Orzechowska, A., Szulc, A., Płaza, O., & Gałecki, P. (2023) · Biomedicines · doi:10.3390/biomedicines11071903 · Cited by 84
“Depression can hinder self-care behaviors, such as medication adherence, regular physical activity, and healthy eating, leading to suboptimal diabetes control and an increased risk of complications [86].”
BackgroundRecognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment
Kruger, D., LaRue, S., & Estepa, P. (2015) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s71923 · Cited by 73
Chapman, A., Liu, S., Merkouris, S., Enticott, J. C., Yang, H., Browning, C. J., & Thomas, S. A. (2015) · Frontiers in Public Health · doi:10.3389/fpubh.2015.00252 · Cited by 70
Relationship between depression and diabetes in pregnancy: A systematic review
Ross, G. P., Falhammar, H., Chen, R., Barraclough, H., Kleivenes, O., & Gallen, I. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i19.554 · Cited by 71
Sulaiman, N., Hamdan, A., Tamim, H., Mahmood, D. A., & Young, D. (2010) · BMC Family Practice · doi:10.1186/1471-2296-11-80 · Cited by 72
“Patients who are depressed struggle with self-care and adherence to their prescribed care regimens [5, 26 ].”
BackgroundWhitworth, S. R., Bruce, D. G., STARKSTEIN, S. E., Davis, W. A., Davis, T. M. E., & Bucks, R. S. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.10.023 · Cited by 80
“0%) in the present study were also equivalent to, or less than, those seen in other studies [3,10,14] suggesting no issues with overdiagnosis.”
BackgroundResultPouwer, F., Schram, M. T., Iversen, M. M., Nouwen, A., & Holt, R. I. G. (2020) · Diabetic Medicine · doi:10.1111/dme.14227 · Cited by 70
SCHMITT, A. J., Kulzer, B., Ehrmann, D., Haak, T., & Hermanns, N. (2022) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.823046 · Cited by 87
Aschner, P. J., Horton, E., Leiter, L. A., Munro, N. M., Skyler, J. S., & Management*, O. B. O. T. G. P. F. E. D. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02296.x · Cited by 78
Akena, D., Kadama, P., Ashaba, S., Akello, C., Kwesiga, B., Rejani, L., Okello, J., Mwesiga, E. K., & Obuku, E. A. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.019 · Cited by 66
Schmitt, A., Reimer, A., Kulzer, B., Haak, T., Gahr, A., & Hermanns, N. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-014-9604-3 · Cited by 56
“impairments of diabetes treatment (Gonzalez et al., 2008) and elevated risks of subsequent long-term complications”
BackgroundDiabetes: Mechanism, Pathophysiology and Management-A Review
Siddiqui, A. A., Siddiqui, S. A., Ahmad, S., Siddiqui, S., Ahsan, I., & Sahu, K. (2013) · International Journal of Drug Development and Research · Cited by 113
Reviewing U.S. connected diabetes care: the newest member of the team
Levine, B. J., Close, K. L., & Gabbay, R. A. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0273 · Cited by 66
Bahrmann, A., Bahrmann, P., Baumann, J., Bauer, J. M., Brückel, E., Dreyer, M., Freitag, M., Friedl, A., Gölz, S., Grundke, S., et al. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/a-0666-0820 · Cited by 71
Akpalu, J., Yorke, E., Ainuson‐Quampah, J., Balogun, W., & Yeboah, K. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1933-2 · Cited by 71
Gilsanz, P., Karter, A. J., Beeri, M. S., Quesenberry, C. P., & Whitmer, R. A. (2017) · Diabetes Care · doi:10.2337/dc17-1566 · Cited by 70
Virtanen, M., Ferrie, J. E., Tabak, A. G., Akbaraly, T. N., Vahtera, J., Singh-Manoux, A., & Kivimäki, M. (2014) · Diabetes Care · doi:10.2337/dc13-2725 · Cited by 65
Camara, A., Balde, N. M., Enoru, S. T., Bangoura, J. S., Sobngwi, E., & Bonnet, F. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.04.007 · Cited by 75
Garrett, C., & Doherty, A. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-6-669 · Cited by 64
Nobis, S., Lehr, D., Ebert, D. D., Berking, M., Heber, E., Baumeister, H., Becker, A., Snoek, F., & Riper, H. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-306 · Cited by 62
“This is of high importance given the negative impact of co-occurrence of diabetes and depression on psychological and medical outcomes, as well as on the health care system [3-7,10,12,14,100].”
BackgroundPozzo, M. J., Mociulsky, J., Martinez, E. T., Senatore, G., Farias, J. M., Sapetti, A., Sanzana, M. G., Gonzalez, P., Cafferata, A., Peloche, A., et al. (2014) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000433949.24277.19 · Cited by 69
“A meta-analysis on the comorbidity of diabetes and depression in over 17,000 patients assessed the strength of association between both diseases.(38) The aim was to determine whether the association between depression and proper diabetes care varied according to selfmanagement measures or type of diabetes (type 1 or t…”
BackgroundInfluentialAzharuddin, M., Adil, M., Sharma, M., & Gyawali, B. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14717 · Cited by 76
Koponen, A. M., Simonsen, N., & Suominen, S. (2017) · Psychology, Health & Medicine · doi:10.1080/13548506.2016.1154179 · Cited by 52
Jaam, M., Ibrahim, M. I. M., Kheir, N., & Awaisu, A. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.04.015 · Cited by 62
“largely underrepresented in these reviews [12-28].”
Rodrigue, J. R., Nelson, D. R., Hanto, D. W., Reed, A. I., & Curry, M. P. (2013) · Progress in Transplantation · doi:10.7182/pit2013501 · Cited by 59
“Clinical assessments of nonadherence risk are based largely on factors associated with medication nonadherence in the nontransplant literature, including mood disturbances, passive coping strategies, substance abuse, prior medication nonadherence, and limited social support.(12-23) Some candidates at high risk for pos…”
BackgroundTrento, M., Raballo, M., Trevisan, M., Sicuro, J., Passera, P., Cirio, L., Charrier, L., Cavallo, F., & Porta, M. (2012) · Acta Diabetologica · doi:10.1007/s00592-011-0275-z · Cited by 60
The Comorbidity between Depression and Diabetes
Oladeji, B. D., & Gureje, O. (2013) · Current Psychiatry Reports · doi:10.1007/s11920-013-0390-3 · Cited by 59
Aikens, J. E., TRIVEDI, R. B., Aron, D. C., & Piette, J. D. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3101-9 · Cited by 62
Lage, M., Boye, K., Curtis, S., & Garcia-Perez, L.-E. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s107543 · Cited by 57
“Specifically, anxiety has been shown to be prevalent in patients with diabetes, 37 comorbid depression has been shown to be linked to nonadherence, 38 and hyperlipidemia has been used in previous studies which examined the relationship between adherence and outcomes.”
Perrin, N., Bodicoat, D. H., Davies, M. J., Robertson, N., Snoek, F. J., & Khunti, K. (2019) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.04.001 · Cited by 53
Chen, F., Wei, G., Wang, Y., Liu, T., Huang, T., Wei, Q., Ma, G., & Wang, D. (2019) · BMC Public Health · doi:10.1186/s12889-019-7392-y · Cited by 63
“One study showed that individuals with undiagnosed depression might be at increased risk for non-adherence to metformin use [50], and other studies have shown that metformin does not improve depression.”
BackgroundNaik, A. D., Hundt, N. E., Vaughan, E. M., Petersen, N. J., Zeno, D., Kunik, M. E., & Cully, J. A. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.8634 · Cited by 57
Zhang, W., Xu, H., Zhao, S., Yin, S., Wang, X., Guo, J., Zhang, S., Zhou, H., Wang, F., Gu, L., et al. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0053-0 · Cited by 54
“The course of depression in patients with diabetes is chronic and severe [52], and has significant effects on the outcome of their medical illness [53], including lower quality of life [54], poorer diabetes self-care [55], and an increased risk of developing diabetes-related complications [32].”
BackgroundGuilfoyle, S. M., Crimmins, N. A., & Hood, K. K. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00735.x · Cited by 60
Döbler, A., Herbeck Belnap, B., Pollmann, H., Farin, E., Raspe, H., & Mittag, O. (2018) · Rehabilitation Psychology · doi:10.1037/rep0000224 · Cited by 55
“…et al., 2000), increased risk of complications from diabetes (de Groot, Anderson, Freedland, Clouse, & Lustman, 2001), poor treatment adherence (Gonzalez et al., 2008; Sumlin et al., 2014), and lower levels of motivation to maintain self-care behavior (Egede & Osborn, 2010); even subclinical…”
BackgroundSarda, A., Munuswamy, S., Sarda, S., & Subramanian, V. (2019) · JMIR mHealth and uHealth · doi:10.2196/11041 · Cited by 56
“Depression increases the risk of nonadherence to medical treatment by 27% to 30% [5-7], which is a significant problem in diabetes self-care.”
Herzer, M., Vesco, A. T., Ingerski, L. M., Dolan, L. M., & Hood, K. K. (2011) · Journal of Behavioral Medicine · doi:10.1007/s10865-010-9307-3 · Cited by 58
“In fact, in the broader child development literature, family conflict is associated with higher levels of anxiety and distress in both children and adolescents ( Ginsburg et al. 2004; Stark et al. 1990).”
BackgroundComorbidities significantly impact patients’ preferences for psoriasis treatments
Schmieder, A., Schaarschmidt, M., Umar, N., Terris, D., Goebeler, M., Goerdt, S., & Peitsch, W. K. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.08.023 · Cited by 66
Cognitive–Behavioral Therapy for Adherence and Depression (CBT-AD) in Type 2 Diabetes
Gonzalez, J. S., McCarl, L. A., Wexler, D. J., Cagliero, E., Delahanty, L., Soper, T. D., Goldman, V., Knauz, R., & Safren, S. A. (2010) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.24.4.329 · Cited by 55
“, 2001; Egede, 2005) and the association of depression with worse treatment adherence (Gonzalez et al., 2008) and diabetes outcomes (de Groot et al.”
BackgroundMethodSelf-citationSuboptimal glycemic control in type 2 diabetes: A key role for anhedonia?
Nefs, G., Pouwer, F., Denollet, J., Krämer, H. U., Gent, C., & Pop, V. J. M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.01.013 · Cited by 61
“As the mechanisms behind the association between emotional distress and glycemic control are still unclear but likely include less adequate self-care behaviors (Gonzalez et al., 2008), we also examined the role of body mass index and several health behaviors as potential mediators of these associations.”
BackgroundInfluentialRéus, G. Z., dos Santos, M. A. B., Strassi, A. P., Abelaira, H. M., Ceretta, L. B., & Quevedo, J. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.025 · Cited by 60
“A systematic review of treatment adherence amongst individuals with DM andMDD showed that there was a significant relationship between MDD and nonadherence to treatment [41].”
BackgroundPsychosoziales und Diabetes (Teil 2)
Kulzer, B., Albus, C., Herpertz, S., Kruse, J., Lange, K., Lederbogen, F., & Petrak, F. (2013) · Diabetologie und Stoffwechsel · doi:10.1055/s-0033-1335889 · Cited by 66
Jung, I., Kwon, H., Park, S. E., Han, K.-D., Park, Y. G., Kim, Y., Rhee, E., & Lee, W. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0008 · Cited by 58
“First, behavioral changes accompanied by mood disorders might worsen glycemic control [29,30].”
BackgroundOris, L., Seiffge‐Krenke, I., Moons, P., Goubert, L., Rassart, J., Goossens, E., & Luyckx, K. (2015) · Journal of Behavioral Medicine · doi:10.1007/s10865-015-9680-z · Cited by 59
Vaala, S. E., Hood, K. K., Laffel, L., Kumah-Crystal, Y. A., Lybarger, C. K., & Mulvaney, S. A. (2015) · interactive Journal of Medical Research · doi:10.2196/ijmr.4504 · Cited by 52
“Keeping daily blood glucose values within the target range also reduces short-term risks for hypoglycemia, hyperglycemia, depression, and other unfavorable outcomes [1,4,5].”
Shirazian, S., Crnosija, N., Weinger, K., Jacobson, A. M., Park, J., Tanenbaum, M. L., Gonzalez, J. S., Mattana, J., & Hammock, A. C. (2015) · Chronic Illness · doi:10.1177/1742395315614381 · Cited by 55
“In patients with diabetes, distress, depressive symptoms, and depression have been linked to poor selfmanagement and glycemic control, although the direction of these relationships remains unclear.(18) Additionally, higher levels of diabetes related distress have been associated with a greater burden of complications…”
BackgroundSelf-citationMeasurement of psychological adjustment to diabetes with the diabetes acceptance scale
Schmitt, A., Reimer, A., Kulzer, B., Icks, A., Paust, R., Roelver, K.-M., Kaltheuner, M., Ehrmann, D., Krichbaum, M., Haak, T., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.01.005 · Cited by 53
Dalsgaard, E.-M., Vestergaard, M., Skriver, M. V., Maindal, H. T., Lauritzen, T., Borch-Johnsen, K., Witte, D., & Sandbaek, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3165-4 · Cited by 53
“a sedentary lifestyle, smoking, poorer intake of healthy food and poorer medication adherence [4, 42].”
BackgroundGeldsetzer, P., Vaikath, M., Wagner, R. G., Rohr, J. K., Montana, L. S., Gómez-Olivé, F. X., Rosenberg, M. S., Manne‐Goehler, J., Mateen, F. J., Payne, C., et al. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly145 · Cited by 53
Montoya, P. A., Gagliardino, J. J., ILKOVA, H. M., Lavalle-Gonzalez, F. J., Ramachandran, A., Mbanya, J. C., Shestakova, M. V., Bourhis, Y., Chantelot, J.-M., & Chan, J. C. N. (2020) · Diabetes Care · doi:10.2337/dc20-2003 · Cited by 61
Hayashino, Y., Mashitani, T., Tsujii, S., Ishii, H., & for the Diabetes Distress and Care Registry at Tenri Study Group (2014) · Diabetes Care · doi:10.2337/dc13-2312 · Cited by 52
“alence of depression (1), particularly that associated with poor treatment adherence and glycemic control (1,2), and a high prevalence of complications (3).”
BackgroundSainsbury, K., & Marques, M. M. (2018) · Appetite · doi:10.1016/j.appet.2017.10.017 · Cited by 45
“…and non-adherence to medication and other treatment components (e.g., diet and physical activity recommendations; DiMatteo, Lepper, & Croghan, 2000; Gonzalez et al., 2008; Grenard et al., 2011), with depressed patients being 1.76-to-3 times less likely to adhere to medical trea ment…”
InfluentialAtlantis, E., Vogelzangs, N., Cashman, K., & Penninx, B. J. W. H. (2012) · Journal of Affective Disorders · doi:10.1016/s0165-0327(12)70006-x · Cited by 51
“, 2008) or adhere to healthy lifestyle guidelines (Gonzalez et al., 2008).”
BackgroundA review of risk factors associated with insulin omission for weight loss in type 1 diabetes
Hall, R., Keeble, L., Sünram‐Lea, S. I., & To, M. P. S. (2021) · Clinical Child Psychology and Psychiatry · doi:10.1177/13591045211026142 · Cited by 61
“Comorbidity of depression and T1D has been found to associate with less adherence to treatment (Gonzalez et al., 2008) and higher HbA1c (van Tilburg et al.”
BackgroundAssociation of Coexisting Diabetes and Depression With Mortality After Myocardial Infarction
Bot, M., Pouwer, F., Zuidersma, M., van Melle, J. P., & de Jonge, P. (2012) · Diabetes Care · doi:10.2337/dc11-1749 · Cited by 48
“, diet, exercise, and smoking cessation) and to reduced medication adherence in diabetic as well as MI patients (30,31).”
BackgroundNurchis, M. C., Sessa, G., Pascucci, D., Sassano, M., Lombi, L., & Damiani, G. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040643 · Cited by 58
Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
Ascher-Svanum, H., Lage, M. J., Perez-Nieves, M., Reaney, M. D., Lorraine, J., Rodriguez, A., & Treglia, M. (2014) · Diabetes Therapy · doi:10.1007/s13300-014-0065-z · Cited by 50
“Conclusion: Among patients with T2DM who were initiated on insulin therapy, early discontinuation of insulin and its subsequent restart were associated with significantly higher acute care costs, which may signal a more complex and challenging subgroup of patients who tend to be less engaged in outpatient care and may…”
ResultInfluentialBeverly, E. A., Ritholz, M. D., & Dhanyamraju, K. (2020) · Diabetic Medicine · doi:10.1111/dme.14472 · Cited by 58
Metadata
- Authors
- Gonzalez, J. S., Peyrot, M., McCarl, L. A., Collins, E. M., Serpa, L., Mimiaga, M. J., & Safren, S. A.
- Affiliations
- Harvard University (US)
- Johns Hopkins University (US)
- Massachusetts General Hospital (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2008-12-01
- Volume
- 31
- Issue
- 12
- Pages
- 2398-2403
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2584202
- OpenAlex
- W2161097799
- Semantic Scholar
- b8fb596e27d9df5134d00819c6f2e6d3c1f29a13
- Cited by
- 1,060
- References
- 43
- Citations by year
- 2026: 57 · 2025: 54 · 2024: 75 · 2023: 61 · 2022: 67 · 2021: 68 · 2020: 79 · 2019: 61 · 2018: 56 · 2017: 68 · 2016: 70 · 2015: 74 · 2014: 64 · 2013: 59 · 2012: 61
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (1r01mh078571-01)
- National Institute of Mental Health (1R01MH078571, R01 MH-078571)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- depression, type 1 diabetes, type 2 diabetes, self-care, missed medical appointments, medication adherence, comorbidities
- MeSH terms
- Depression, Diabetes Mellitus, Humans, Patient Compliance, Treatment Refusal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.